The research investigates the timelines and therapies used in treating pediatric hidradenitis suppurativa.
Analyzed treatment initiation timings across different demographics
Reviewed initial treatment types provided to pediatric patients
Evaluated patterns in switching treatments over time
Identified delays in treatment initiation across several demographic groups
Noted that initial therapies primarily consisted of antibiotic treatments
Observed significant variation in treatment escalation practices
Abstract
Pediatric HS care is characterized by delayed treatment escalation, antibiotic-dominant initial therapy, and variation in treatment initiation timing across demographic groups.